HomeAMRS • BMV
add
Amyris Ord Shs
Previous close
$1.00
Year range
$1.00 - $14.59
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2023info | Y/Y change |
---|---|---|
Revenue | 56.08M | -2.82% |
Operating expense | 96.47M | -10.02% |
Net income | -193.34M | -80.18% |
Net profit margin | -344.74 | -85.40% |
Earnings per share | -0.34 | 8.11% |
EBITDA | -111.78M | 7.82% |
Effective tax rate | 0.42% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 11.24M | -96.09% |
Total assets | 679.68M | -24.35% |
Total liabilities | 1.33B | 28.99% |
Total equity | -648.07M | — |
Shares outstanding | 369.39M | — |
Price to book | -0.56 | — |
Return on assets | -39.09% | — |
Return on capital | -65.70% | — |
Cash Flow
Net change in cash
(USD) | Mar 2023info | Y/Y change |
---|---|---|
Net income | -193.34M | -80.18% |
Cash from operations | -90.00M | 40.96% |
Cash from investing | -4.82M | 89.82% |
Cash from financing | 41.61M | 951.39% |
Net change in cash | -53.15M | 72.83% |
Free cash flow | -36.29M | 66.66% |
About
Amyris, Inc. is a synthetic biotechnology and renewable chemical company headquartered in Emeryville, California. Amyris serves the specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, pharmaceuticals, and nutraceuticals markets. Wikipedia
CEO
Founded
2003
Website
Employees
1,598